Information Provided By:
Fly News Breaks for February 17, 2016
MRTX
Feb 17, 2016 | 07:09 EDT
Jefferies analyst Brian Abrahams assumed coverage of Mirati Therapeutics with a Buy rating and $33 price target.
News For MRTX From the Last 2 Days
There are no results for your query MRTX